Login / Signup

Long non-coding RNA SNHG5 promotes the osteogenic differentiation of bone marrow mesenchymal stem cells via the miR-212-3p/GDF5/SMAD pathway.

Yineng HanQiaolin YangYiping HuangLingfei JiaYunfei ZhengWeiran Li
Published in: Stem cell research & therapy (2022)
Our results demonstrated that the novel pathway YY1/SNHG5/miR-212-3p/GDF5/Smad regulates osteogenic differentiation of hBMSCs and may serve as a potential target for the treatment of bone loss.
Keyphrases
  • long non coding rna
  • poor prognosis
  • bone loss
  • epithelial mesenchymal transition
  • transforming growth factor
  • risk assessment
  • combination therapy